Share-based Payment Arrangement, Expense of Zenas BioPharma, Inc. from 30 Sep 2023 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Zenas BioPharma, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Sep 2023 to 30 Sep 2025.
  • Zenas BioPharma, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $7,336,000, a 158% increase year-over-year.
  • Zenas BioPharma, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $24,262,000.
  • Zenas BioPharma, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $10,821,000, a 210% increase from 2023.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Zenas BioPharma, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $24,262,000 $7,336,000 +$4,493,000 +158% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $19,769,000 $6,045,000 +$4,509,000 +294% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $15,260,000 $5,386,000 +$4,439,000 +469% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $10,821,000 $5,495,000 01 Oct 2024 31 Dec 2024 10-K 11 Mar 2025 2024 FY
Q3 2024 $2,843,000 +$1,840,000 +183% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3
Q2 2024 $1,536,000 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025 2025 Q2
Q1 2024 $947,000 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q3 2023 $1,003,000 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3

Zenas BioPharma, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $10,821,000 +$7,326,000 +210% 01 Jan 2024 31 Dec 2024 10-K 11 Mar 2025 2024 FY
2023 $3,495,000 01 Jan 2023 31 Dec 2023 10-K 11 Mar 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.